ImpediMed is an ASX 300 company, and one of the fastest growing small companies on the ASX.
ImpediMed is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed’s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphedema. ImpediMed has the first medical device with an FDA clearance in the United States to aid health care professionals clinically assess secondary unilateral lymphedema of the arm and leg in women and the leg in men.As we expand we will require new employees to help develop and market our compelling product range.
- Clinical Trials Manager